A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects

Inclusion criteria: * Male or female non-smoking subject. * Lack of clinically significant abnormalities in health assessments performed at screening as deemed by the Investigator (or designee) * BMI within the range (including the borders) of 18.5 to 29.9 kg/m2 Exclusion criteria: * Medical history or presence of ANY current dermatological condition such as atopy, psoriasis, eczema, chronic or atopic dermatitis, vitiligo, or urticaria which, in the opinion of the Investigator, would compromise the safety of the subject or the integrity of the study * Medical history or current evidence, as determined by the Investigator, of chronic infectious disease, system disorders, seizure disorders, or cardiovascular disorders (especially hypertension or family history of sudden cardiac death) * Medical history of a condition that would significantly influence the immune response (e.g., primary or acquired immunodeficiencies such as HIV or AIDS; allergic diseases such as anaphylaxis, asthma, or generalized drug reaction; neoplasms such as lymphoma or leukemia; rheumatoid arthritis; or systemic lupus erythematosus) * Clinically significant illness within 4 weeks before screening visit